MedTrace Logo

Left-Atrium-Appendage Occluder Register - GErmany

NCT02230748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 643

Last updated 2018-09-06

No results posted yet for this study

Summary

* Evaluation of safety and effectiveness of implantable LAA occluder in clinical practice
* Indication: For which reasons is the indication for implantation of LAA-Occluder put for patients with atrial fibrillation?
* Safety: How save is the implantation of LAA-Occluders?
* Effectiveness: How effective is implantation of LAA-Occluders in daily clinical practice?
* Concomitant treatment: Which concomitant treatment is prescribed for patients with LAA-Occluder?

Conditions

Sponsors & Collaborators

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Jochen Senges, MD · Stiftung Institut für Herzinfarktforschung (IHF)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-01-31
Completion
2017-03-27

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230748 on ClinicalTrials.gov